Status:
COMPLETED
Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy
Lead Sponsor:
Pfizer
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study aims at estimating the proportion of patients diagnosed with locoregional renal cell carcinoma who are at high risk for recurrence following nephrectomy, describe referral patterns, and cha...
Eligibility Criteria
Inclusion
- Patients must meet all of the following inclusion criteria to be eligible for data abstraction:
- Diagnosed with locoregional RCC (no distant metastasis at the time of diagnosis)
- Underwent a nephrectomy at Duke between 01 April 2014, and 31 December 2019 (final dates determined based on results from part 2 data collection)
- Aged 18 years or older at nephrectomy
Exclusion
- none
Key Trial Info
Start Date :
July 31 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 28 2020
Estimated Enrollment :
618 Patients enrolled
Trial Details
Trial ID
NCT04309617
Start Date
July 31 2019
End Date
April 28 2020
Last Update
May 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University
Durham, North Carolina, United States, 27710